Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction

Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction

Bibliographic Details
Main Authors:	Maurizio Provenzano, Abdou Kamal Allayeh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer liquid biopsy small DNA viruses polyomavirus large T antigen
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00778/full

Similar Items

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

The results of transrectal prostate biopsy in patients with low levels of prostate specific antigen
by: Ahmet Ali Sancaktutar, et al.
Published: (2012-06-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
by: Milena Matuszczak, et al.
Published: (2021-07-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
by: Won Ki Lee, et al.
Published: (2014-08-01)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
by: Gokhan Koc, MD, et al.
Published: (2017-01-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy
by: Andrea Fabiani, et al.
Published: (2018-06-01)

Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
by: Selcuk Sarıkaya, et al.
Published: (2014-12-01)

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
by: Igor Brikun, et al.
Published: (2018-07-01)

Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis
by: Zhengfan Gao, et al.
Published: (2021-05-01)

The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice
by: Michael Thüring, et al.
Published: (2020-08-01)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
by: Oktay Uçer, et al.
Published: (2015-10-01)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
by: Vincenzo Di Nunno, et al.
Published: (2018-09-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
by: Ahmed S. Zakaria, et al.
Published: (2018-08-01)

A Study on TRUS-Guided Prostatic Biopsy and its Correlation with Serum PSA, Gleason Score and Grade-Grouping in a Tertiary Care Centre of Eastern India
by: GOPINATH BARUI, et al.
Published: (2019-03-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4–10 ng ml−1)
by: Jun Liu, et al.
Published: (2020-01-01)

Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study
by: Yi Wang, et al.
Published: (2016-01-01)

Transrectal Ultrasound Guided Prostatic Biopsy and its Complications: A Descriptive Cross-sectional Study
by: Robin Joshi
Published: (2020-01-01)

Evaluation of concordance between histopathological prognostic findings from prostate needle biopsy samples and serum prostate-specific antigen levels
by: Cengiz Kocak
Published: (2019-03-01)

Phosphorylation of Large T Antigen Regulates Merkel Cell Polyomavirus Replication
by: Jason Diaz, et al.
Published: (2014-07-01)

Between a Short-term and a Long-term antimicrobial prophylaxis in prostate biopsy: The applicability in a low-resource setting
by: Friday Emeakpor Ogbetere, et al.
Published: (2021-01-01)

Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
by: Marta Toledano-Fonseca, et al.
Published: (2020-07-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
by: Jeremy YC Teoh, et al.
Published: (2015-01-01)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
by: Isabel Heidrich, et al.
Published: (2021-09-01)

Frequency of the morphological criteria of prostate adenocarcinoma in 387 consecutive prostate needle biopsies: emphasis on the location and number of nucleoli
by: Andrea O. Cruz, et al.

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: W. F. S. Busato, et al.
Published: (2015-04-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

An overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy
by: Sujata K Patwardhan, et al.
Published: (2018-01-01)

Chronic inflammation of the prostate type IV with respect to risk of prostate cancer
by: Antonio B. Porcaro, et al.
Published: (2014-09-01)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
by: Jochen Neuhaus, et al.
Published: (2018-09-01)